BUY Biocon Ltd — Ratnesh Goyel, Arihant Capital Markets
byRatnesh Goyel, Arihant Capital MarketsHorizon: 1–3 months15 Jul 2026via Business Today
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Biocon shares rise 3% after Rs 638-crore block deal; Active Pine likely seller
NewsEt-Markets·9 Sept · 1w ago
Biocon shares gain nearly 3% after equity worth ₹630 crore changes hands in block deal
NewsCnbc-Tv18·9 Sept · 1w ago
Biocon sees double-digit biosimilars growth continuing, targets mid-20% margins
NewsCnbc-Tv18·8 Sept · 1w ago
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
NewsEt-Markets·8 Sept · 1w ago
Biocon shares gain after bagging 10-year contract in Brazil for Breast Cancer treatment drug
NewsCnbc-Tv18·8 Sept · 1w ago
Biocon Block Deal: Active Pine likely to sell 1.66 crore shares at ₹385 per share
NewsCnbc-Tv18·8 Sept · 1w ago
Biocon Block Deal: True North Likely To Sell Rs 640-Crore Stake, Sources Say
NewsNdtv-Profit·8 Sept · 1w ago
Buy, Sell Or Hold: IndiGo, Maruti Suzuki, Biocon, LIC, Hindustan Copper, Bharat Dynamics — Ask Profit
NewsNdtv-Profit·2 Sept · 2w ago
Buy, Sell Or Hold: Mahindra & Mahindra, Coforge, TVS Motor, Biocon And Divi's Labs — Ask Profit
NewsNdtv-Profit·30 Aug · 2w ago
Buy, Sell Or Hold: Mazagon Dock, HAL, Biocon, Suzlon And Tata Motors PV — Ask Profit
NewsNdtv-Profit·18 Aug · 4w ago
Biocon shares: Active Pine may divest up to 1% equity worth Rs 638 crore via block deal
NewsEt-Markets·8 Sept · 1w ago
3 advisors have active long-term SELL calls on this stock
Advisor consensus · adjacent horizon·15 Jul · 2mo ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Biocon
- BUY — Kunal Bothra22 Oct 2026 · ~2 weeks · target ₹345 · SL hit
- SELL — Rajesh Satpute9 Oct 2026 · ~3 months · target ₹335 · Active
- BUY — Axis Securities19 Sept 2026 · ~3 months · target ₹424 · Active
- BUY — Prakash Gaba17 Sept 2026 · ~2 weeks · target ₹390 · Target hit
- BUY — Vikas Salunkhe, Nirmal Bang Securities27 Aug 2026 · ~2 weeks · target ₹440 · SL hit
More from Ratnesh Goyel, Arihant Capital Markets
- BUY Mishra Dhatu Nigam9 Sept 2026 · ~3 months · target ₹540 · SL hit
- BUY Craftsman Automation9 Sept 2026 · ~2 weeks · target ₹13,000 · Expired
- BUY UNO Minda9 Sept 2026 · ~3 months · target ₹1,500 · SL hit
- BUY State Bank of India9 Sept 2026 · ~2 weeks · target ₹1,150 · Expired
- BUY Power Finance Corporation9 Sept 2026 · ~2 weeks · target ₹393 · Expired

